Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Orchard Therapeutics plc (ORTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
   10-K10-K10-K10-K10-K10-K20-F
Net income  -150.7-144.6-152.0-163.4-230.5-39.7-19.1
Depreciation and amortization   [+]2.72.32.01.71.20.30.0
Asset impairment charges    5.7    
Stock-based compensation    28.019.46.81.00.2
Deferred taxes    -2.3-2.9   
Change in working capital   [+]34.359.727.418.690.210.86.0
Other operating activities  37.6-42.5-35.0-39.534.8-4.9-1.7
Cash from operations  -76.0-125.1-126.3-166.1-97.5-32.5-14.6
   
Capital expenditures  6.52.3-2.7-4.4-4.0-1.6-0.2
Purchases of short-term investments, net  112.3263.9158.2-305.0   
Other cash from investing  -28.2-298.41.9    
Cash from investing  90.6-32.2157.4-309.4-4.0-1.6-0.2
   
Issuance of common stock, net     130.3209.7  
Option exercises  0.23.33.95.30.0  
Other cash from financing  -0.5161.47.832.5145.2115.718.0
Cash from financing  -0.7158.13.9157.5354.9115.718.0
   
Free cash flow  -69.5-122.7-128.9-170.5-101.6-34.0-14.8
        Per share (diluted)  ($0.54)($0.99)($1.30)($1.83)($4.50)($3.84)($2.08)
   
Cash paid for interest  2.62.11.81.2   
Cash paid for income taxes  0.21.71.01.5   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy